Victoria Meissner | VP, Strategy & IR |
Ugur Sahin | Co-Founder & CFO |
Ozlem Tureci | Chief Medical Officer & Co-Founder |
Jens Holstein | CFO |
Ryan Richardson | Chief Strategy Officer |
Daina Graybosch | Leerink Partners |
Tazeen Ahmad | Bank of America |
Chris Shibutani | Goldman Sachs |
Brendan Smith | TD Cowen |
Terence Flynn | Morgan Stanley |
Bill Maughan | Canaccord |
Simon Baker | Redburn |
Welcome to BioNTech's Second Quarter 2023 Update Call.
I would like to hand the call over to Dr. Victoria Meissner, Vice President of Strategy and Investor Relations. Please go ahead.
Thank you.